amortization and taxes (23.0) (77.8)
Net loss applicable to common stock $(72.2) $(210.1)
Per diluted share:
Net operating income (loss) before
valuation allowance for deferred tax assets $.10 $ (.37)
Valuation allowance for deferred tax assets (.37) (.39)
Net operating loss (.27) (.76)
Net realized investment losses, net of
related amortization and taxes (.12) (.45)
Net loss applicable to common stock $(.39) $(1.21)
In the fourth quarter of 2007, several items had noteworthy impacts on
our results:
-- Earnings in the Conseco Insurance Group segment were negatively
affected by the adjustments we made to our estimates of future profits
for certain interest-sensitive life blocks of business. These
adjustments resulted in increases to amortization expense and
policyholder benefits totaling approximately $17 million.
-- Earnings in the Conseco Insurance Group segment were also negatively
affected by $4.2 million of trading losses related to the termination
of interest rate swap agreements held in our trading portfolio.
-- Earnings in the Colonial Penn segment were negatively impacted by $8.4
million of expense related to the introduction of Medicare Advantage
products through this distribution channel.
-- Based on our evaluation of deferred tax assets, we determined the need
to increase the valuation allowance by $68.0 million (primarily related
to tax benefits resulting from the losses recognized in 2007).
-- We recognized net realized investment losses of $23.0 million,
including losses related to impairments of $16.1 million.
Sales results
'/>"/>
| SOURCE Conseco, Inc. Copyright©2008 PR Newswire. All rights reserved |